Retinal Angiomatous Proliferation (RAP) was described by Yannuzzi and co-workers as a distinct form of neovascular Age-Related Degeneration (AMD). Disease RAP is a neovascularization that starts at the retina and progresses posteriorly into sub retinal space; eventually the neovascularization reaches the choroidal circulation and forms retinal ...

（MNV3, type 3 macular neovascularization），也就是以前常说的视网膜血管瘤样增生（RAP, retinal angiomatous proliferation），是一种独特的新生血管性年龄相关性黄斑变性（AMD）类型。 近期的组织病理学和多模态影像学观察结果，对年龄相关性黄斑变性（AMD）中的新术语“3 型黄斑新生血管（MNV3）”达成了共识定义。 AMD的分型问题. AMD是根据疾病的临床表现特点来分型的，即干性AMD和湿性AMD。 在AMD中，干性AMD所占比例最大，大约是85%，主要表现 …

2022年9月14日 · Type 3 MNV, also known as retinal angiomatous proliferation (RAP), is characterised by anomalous vascular complexes originating in the neuroretinal layers .

视网膜血管瘤样增生（rap）为老年性黄斑变性（amd）的一种亚型，又称为3型脉络膜新生血管（cnv），发病率较低。 临床特点主要有视网膜网状玻璃膜疣、视网膜色素上皮（RPE）脱离、视网膜脉络膜吻合体（RCA）形成、易发生RPE撕裂和地图状萎缩（GA）。

2024年10月11日 · Type 3 macular neovascularization (MNV) is a unique form of neovascular age-related macular degeneration (AMD) that presents distinct pathogenetic features, clinical...

2024年2月8日 · MNV. 在最新的国际AMD命名专家共识中，鉴于AMD中特殊类型视网膜血管瘤样增生（retinal angiogmatous proliferation，RAP）的新生血管来源于视网膜，而非脉络膜，使用“CNV”无法准确涵盖AMD中所有类型的新生血管，建议将既往使用的术语CNV更换为MNV。

We discuss the etiology and clinical features of MNV, the role of multimodal imaging in establishing the diagnosis, and the available therapeutic options. Choroidal neovascularization (CNV) refers to angiogenesis within the macula, generally arising from the choriocapillaris, that results from several chorioretinal diseases.

2021年4月1日 · Type 3 macular neovascularization (MNV), also called retinal angiomatous proliferation (RAP), is a subtype of neovascular age-related macular degeneration (AMD) that is characterized by retinal-retinal or retinal-choroidal anastomosis infiltrate the neurosensory retina, and communicate with the retinal circulation in what has been referred to ...

Purpose: To report on patients with macular neovascularisation type III (MNV3) arising from cilioretinal arteries (CRAs) (cilioretinal macular neovascularisation type III (cMNV3)). Methods: We reviewed baseline examinations of patients with neovascular age-related macular degeneration using multimodal imaging.

Better visual outcomes can be achieved by treating RAP lesions with intravitreal ranibizumab (39,40,44,74,75), bevacizumab (76,77) and most recently aflibercept (78). Data from clinical trials suggests that the response of RAP lesions to CNV treatments may be similar to that of other variants of neovascular AMD (79).